March 9, 2026

RadNet, Inc. (RDNT) Stock Analysis: Potential 52% Upside in Healthcare Diagnostics

RadNet, Inc. (RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing the attention of investors with its robust growth potential and innovative offerings..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 209% Potential Upside in Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is creating a buzz among investors with its remarkable potential upside, estimated at 209.42%. This biopharmaceutical company, headquartered in Somerset, New Jersey, is making waves..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking a 23.31% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector, particularly in the diagnostics and research industry, should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX). With a market capitalization of $48.58 billion, this American..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 21.55% Potential Upside in the Healthcare Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $4.45 billion, TransMedics is making significant..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 22.47% Potential Upside in the Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) presents an intriguing opportunity for investors within the healthcare sector, specifically in the field of medical devices. With a market capitalization of $1.83 billion,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Lucrative 6.74% Upside Amidst Robust Revenue Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a leading player in the medical devices sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 9.59% Upside with Solid Dividend Yields

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable giant in the healthcare sector, stands out with its impressive $56.49 billion market capitalization. Headquartered in Tokyo, Japan, Takeda has built a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 50.91% Upside Potential Awaits Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator in the biotechnology industry, is making waves with its cutting-edge treatments targeting muscle function. With a market cap of $7.39 billion, the company..

Atrium Therapeutics (RNA) Stock Report: Navigating the Biotech Sector with a Market Cap of $229.93 Million

Atrium Therapeutics, Inc. (RNA) is carving its niche in the dynamic biotechnology sector, with a particular focus on RNA therapeutics aimed at treating cardiomyopathies. Headquartered in San Diego, California, this..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 39.64% Potential Upside in Healthcare Innovation

Bio-Techne Corp (NASDAQ: TECH) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $8.43 billion and a robust portfolio of life..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Capitalizing on a 49.91% Potential Upside with Groundbreaking Biopharma Innovations

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical firm, is capturing significant attention in the biotechnology sector due to its pioneering focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts,..

Glaukos Corporation (GKOS) Stock Analysis: Understanding the 25% Potential Upside

Glaukos Corporation (NYSE: GKOS), a leader in the medical devices sector with a focus on ophthalmic pharmaceuticals and medical technology, has been making waves in the healthcare industry. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 83.84% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing investor attention with its remarkable potential upside of 83.84%, as evidenced by the average analyst target price of $109, compared to its current trading..

Haleon plc (HLN) Stock Analysis: Navigating a 16.03% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a pivotal player in the healthcare sector, presents a compelling investment opportunity with a notable potential upside of 16.03%, according to the latest analyst ratings. Operating from..

Quest Diagnostics (DGX) Stock Analysis: Unlocking a 9.68% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. With a market cap..

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Alcon Inc. (ALC) Investor Outlook: Exploring a 15.94% Potential Upside in the Eye Care Giant

For investors seeking opportunities in the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling case. With a significant market cap of $40.65 billion, this Swiss-based leader in the medical..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Potential Upside Shines Amid Analyst Confidence

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a noteworthy player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market cap of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating a 20% Upside Potential Amidst Stable Revenue Growth

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing attention from investors due to its promising growth potential and..

Option Care Health, Inc. (OPCH) Stock Analysis: Strong Buy Ratings Point to 34% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector specializing in home and alternate site infusion services, is capturing investor attention with its robust growth prospects and..

Search

Funds

March 9, 2026

Search

Funds

March 9, 2026

FTSE 100

Funds